# RDR-006_PREPARATION.md

**Status:** PHASE A COMPLETE — LOCKED PHILOSOPHY FOR PHASE B DRAFTING

**Project:** 12-Gene Gastric Cancer Signature — Part 2: Modernized Biomarker Discovery Framework

**Purpose:** Preparation document for drafting **RDR-006_Interpretability_and_Clinical_Translation_Methodology.md**

**Governed by:** PROJECT_GOVERNANCE_PROMPT_v4.5.1.md

**Audience:** Technical Writer (Claude)

---

# 1. Purpose of this Document

This document records the outcomes of the completed Phase A discussion between the Project Coordinator and the Framework Architect.

Its purpose is to provide the authoritative design contract for drafting RDR-006.

The decisions recorded here are considered locked for Phase B.

They must be implemented faithfully during drafting and must not be redesigned.

---

# 2. Scope of RDR-006

RDR-006 specializes the framework architecture for the **Interpretability and Clinical Translation Layer**.

It builds directly upon:

* RDR-000 (Project Foundation)
* RDR-001 (Framework Architecture)
* RDR-002 (Methodology Architecture)
* RDR-003 (Discovery Methodology)
* RDR-004 (Modeling Methodology)
* RDR-005 (Validation and Benchmark Methodology)

RDR-006 is an architecture and methodology specialization.

It is **not**:

* implementation
* IDS
* algorithm selection
* software specification
* statistical methodology specification

Implementation decisions remain outside the scope of this document.

---

# 3. Locked Interpretability & Clinical Translation Objective

The Interpretability and Clinical Translation Layer exists to enrich Validated Candidates with biological interpretation, model explanation, and clinical translation, enabling transparent understanding and appropriate downstream use.

This layer does **not** create a new candidate type.

This layer does **not** perform framework-wide reporting, framework-wide recommendation, or framework integration.

Those responsibilities remain outside RDR-006.

---

# 4. Locked Interpretability Philosophy

Interpretability is inherently **multi-dimensional**.

No single interpretability perspective dominates.

The framework treats interpretability as complementary evidence across multiple dimensions, including:

* Biological interpretation
* Model explanation
* Evidence interpretation
* Clinical interpretation

These dimensions collectively enrich understanding of a Validated Candidate.

RDR-006 must preserve this multi-dimensional philosophy throughout.

---

# 5. Locked Clinical Translation Philosophy

Clinical Translation is defined as:

> **Any methodology that translates framework outputs into meaningful clinical context.**

Clinical Translation is therefore a general architectural concept rather than a particular methodology.

RDR-006 must remain methodology-agnostic.

Specific clinical translation approaches are future methodology decisions rather than architectural assumptions.

---

# 6. Historical Benchmark Philosophy

Although Clinical Translation is defined broadly, the historical Part 1 workflow remains an essential benchmark pathway.

Within RDR-006 this historical pathway is reconstructed conceptually as:

```
Validated Candidate
        ↓
Nomogram
        ↓
Calibration
        ↓
Decision Curve
        ↓
Clinical Interpretation
```

This historical pathway is treated exactly as previous historical pathways:

* one governed pathway
* not the mandatory architecture
* not the default recommendation
* one benchmark instantiation inside the framework

This preserves consistency with RDR-003 through RDR-005.

---

# 7. Locked Layer Boundary

Interpretability and Clinical Translation constitute a **single architectural layer**.

They are not separated into independent framework layers.

The downstream progression is fixed as:

```
Discovery Candidate
        ↓
Model Candidate
        ↓
Validated Candidate
        ↓
Interpretability &
Clinical Translation
(enrichment)
        ↓
Framework Integration
```

Framework Integration remains a separate downstream stage.

---

# 8. Candidate Philosophy

No additional candidate type is introduced.

RDR-006 does **not** create concepts such as:

* Interpreted Candidate
* Clinical Candidate
* Translation Candidate

The framework's candidate evolution remains:

```
Discovery Candidate
        ↓
Model Candidate
        ↓
Validated Candidate
```

Interpretability and Clinical Translation enrich the existing Validated Candidate rather than replacing or extending it with a new candidate class.

---

# 9. Modernization Philosophy

Modernization within RDR-006 focuses primarily on improving:

* Interpretability
* Explainability

The objective is to expand the framework's ability to generate transparent and explainable scientific outputs while preserving appropriate clinical translation.

Historical methodology remains a valid governed pathway.

Modernization does not imply replacement.

---

# 10. Scope of Interpretability

The layer should focus on three major domains:

1. Biological interpretation

2. Model explanation

3. Clinical translation

These represent the intended architectural responsibilities of the layer.

---

# 11. Explicit Out-of-Scope Responsibilities

The following belong to **Framework Integration**, not RDR-006:

* Framework-wide reporting
* Scientific communication
* Clinical reporting
* Framework-wide recommendation
* End-to-end framework presentation
* Final integrated framework outputs

RDR-006 should not anticipate or absorb these responsibilities.

---

# 12. Success Criterion

The purpose of RDR-006 is not to create another candidate.

Success is achieved when:

> **A Validated Candidate has been sufficiently enriched through biological interpretation, model explanation, and clinical translation to support transparent downstream Framework Integration.**

Interpretability and Clinical Translation therefore complete the scientific understanding of a Validated Candidate without altering its identity.

---

# 13. Drafting Instructions for the Technical Writer

The Phase B draft should follow the same architectural style established by RDR-003, RDR-004, and RDR-005.

The document should include analogous sections, including:

* Executive Summary
* Relationship to Prior Governance
* Locked Philosophy
* Layer Philosophy
* Internal Architecture
* Candidate Enrichment
* Evidence
* Benchmark Philosophy
* Layer Boundary
* Governance
* Methodology Boundaries
* Governance Status

Maintain full architectural symmetry with the previous methodology RDRs.

---

# 14. Drafting Constraints

The Technical Writer shall NOT:

* redesign any philosophy locked above
* introduce new candidate types
* redefine Framework Integration
* introduce implementation
* introduce algorithms
* introduce software packages
* introduce statistical procedures
* introduce hyperparameters
* introduce IDS content

The document must remain a conceptual architecture and methodology specialization only.

---

# 15. Expected Outcome

The resulting RDR-006 should complete the methodology specialization series:

* RDR-003 — Discovery
* RDR-004 — Modeling
* RDR-005 — Validation
* RDR-006 — Interpretability & Clinical Translation

while preserving complete architectural consistency across the entire framework.

---

## Governance Status

**Status:** PHASE A COMPLETE — PHILOSOPHY LOCKED

**Implementation:** NOT PERMITTED

**Next Step:**

1. Technical Writer drafts **RDR-006_Interpretability_and_Clinical_Translation_Methodology.md**
2. Strategist Review
3. Project Coordinator Review
4. Revision Cycle (if required)
5. Official LOCK
6. Generate **RDR-006_CLOSURE.md**
7. Update **PROJECT_STATUS.md**
